Literature DB >> 19064959

Insulin-insulin-like growth factor axis and colon cancer.

Srikala S Sridhar, Pamela J Goodwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19064959     DOI： 10.1200/JCO.2008.19.8937

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  27 in total

1.  Glucose-dependent insulinotropic polypeptide stimulates the proliferation of colorectal cancer cells.

Authors:  Daniel Prabakaran; Baogui Wang; Joseph D Feuerstein; Jennifer A Sinclair; Priti Bijpuria; Lisa I Jepeal; M Michael Wolfe
Journal:  Regul Pept       Date:  2010-04-28

2.  Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.

Authors:  Wambui G Gathirua-Mwangi; Patrick O Monahan; Mwangi J Murage; Jianjun Zhang
Journal:  Cancer Causes Control       Date:  2017-01-17       Impact factor: 2.506

3.  Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy.

Authors:  Francesca D'Addio; Stefano La Rosa; Anna Maestroni; Peter Jung; Elena Orsenigo; Moufida Ben Nasr; Sara Tezza; Roberto Bassi; Giovanna Finzi; Alessandro Marando; Andrea Vergani; Roberto Frego; Luca Albarello; Annapaola Andolfo; Roberta Manuguerra; Edi Viale; Carlo Staudacher; Domenico Corradi; Eduard Batlle; David Breault; Antonio Secchi; Franco Folli; Paolo Fiorina
Journal:  Cell Stem Cell       Date:  2015-10-01       Impact factor: 24.633

4.  Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population.

Authors:  Jeffrey A Meyerhardt; Candyce H Kroenke; Carla M Prado; Marilyn L Kwan; Adrienne Castillo; Erin Weltzien; Elizabeth M Cespedes Feliciano; Jingjie Xiao; Bette J Caan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-16       Impact factor: 4.254

5.  Promotion and selection by serum growth factors drive field cancerization, which is anticipated in vivo by type 2 diabetes and obesity.

Authors:  Harry Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-01       Impact factor: 11.205

6.  Prediagnosis Sleep Duration, Napping, and Mortality Among Colorectal Cancer Survivors in a Large US Cohort.

Authors:  Qian Xiao; Hannah Arem; Ruth Pfeiffer; Charles Matthews
Journal:  Sleep       Date:  2017-04-01       Impact factor: 5.849

Review 7.  Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.

Authors:  Alexandra M Fajardo; Gary A Piazza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-05-28       Impact factor: 4.052

Review 8.  Obesity and cancer risk: recent review and evidence.

Authors:  Karen Basen-Engquist; Maria Chang
Journal:  Curr Oncol Rep       Date:  2011-02       Impact factor: 5.075

9.  Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.

Authors:  Whalen Clark; Erin M Siegel; Y Ann Chen; Xiuhua Zhao; Colin M Parsons; Jonathan M Hernandez; Jill Weber; Shalini Thareja; Junsung Choi; David Shibata
Journal:  J Am Coll Surg       Date:  2013-03-21       Impact factor: 6.113

10.  Association of insulin-related serum factors with colorectal polyp number and type in adult males.

Authors:  Sarah S Comstock; Diana Xu; Kari Hortos; Bruce Kovan; Sarah McCaskey; Dorothy R Pathak; Jenifer I Fenton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-24       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.